{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T20:25:12Z","timestamp":1780345512343,"version":"3.54.1"},"reference-count":83,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.euf.2016.08.010","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T20:15:38Z","timestamp":1472847338000},"page":"374-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Inflammation, Microbiota, and Prostate Cancer"],"prefix":"10.1016","volume":"2","author":[{"given":"Martin","family":"Puhr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"De Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall Scott","family":"Lucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Sfanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasan","family":"Yegnasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Culig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2016.08.010_bib0420","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrc2090","article-title":"Inflammation in prostate carcinogenesis","volume":"7","author":"de Marzo","year":"1999","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.euf.2016.08.010_bib0425","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/jnci\/90.10.756","article-title":"Clinical characteristics and biopsy specimen features in African-American and white men without prostate cancer","volume":"90","author":"Eastham","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euf.2016.08.010_bib0430","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1593\/neo.06373","article-title":"Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model","volume":"8","author":"Borovsky","year":"2006","journal-title":"Neoplasia"},{"key":"10.1016\/j.euf.2016.08.010_bib0435","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1158\/0008-5472.CAN-06-1336","article-title":"The dietary charred meat carcinogene 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate","volume":"67","author":"Nakai","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.euf.2016.08.010_bib0440","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1158\/1940-6207.CAPR-15-0090","article-title":"Bacterial prostatitis enhances 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP)-induced cancer at multiple sites","volume":"8","author":"Sfanos","year":"2015","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.euf.2016.08.010_bib0445","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/aje\/kwq175","article-title":"Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk","volume":"172","author":"Salinas","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.euf.2016.08.010_bib0450","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-3-0348-0837-8_7","article-title":"The role of inflammation in prostate cancer","volume":"816","author":"Sfanos","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.euf.2016.08.010_bib0455","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1073\/pnas.0810473106","article-title":"Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer","volume":"106","author":"Sfanos","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.euf.2016.08.010_bib0460","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrurol.2011.22","article-title":"The etiology and management of acute prostatitis","volume":"8","author":"Brede","year":"2011","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euf.2016.08.010_bib0465","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/pros.22648","article-title":"A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propinibacterium acnes","volume":"73","author":"Shinohara","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.euf.2016.08.010_bib0470","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2559.2011.04033.x","article-title":"Prostate cancer and inflammation: The evidence","volume":"60","author":"Sfanos","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.euf.2016.08.010_bib0475","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11934-005-0029-y","article-title":"Prostatitis and serum prostate-specific antigen","volume":"6","author":"Sindhwani","year":"2005","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.euf.2016.08.010_bib0480","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0022-5347(05)00892-X","article-title":"Sexually transmitted infections and prostatic inflammation\/cell damage as measured by serum prostate specific antigen concentration","volume":"175","author":"Sutcliffe","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2016.08.010_bib0485","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1054\/bjoc.1999.0986","article-title":"Sexual behavior, STDs, and risks for prostate cancer","volume":"82","author":"Hayes","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.euf.2016.08.010_bib0490","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"Vetizou","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.euf.2016.08.010_bib0495","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrurol.2014.361","article-title":"The microbiome of the urinary tract\u2014A role beyond infection","volume":"12","author":"Whiteside","year":"2015","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euf.2016.08.010_bib0500","doi-asserted-by":"crossref","first-page":"e14116","DOI":"10.1371\/journal.pone.0014116","article-title":"Characteristic male urine microbiomes associate with asymptomatic sexually transmitted infection","volume":"5","author":"Nelson","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.euf.2016.08.010_bib0505","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0090-4295(00)00776-7","article-title":"Morphologic transitions between proliferative inflammatory atrophy and high-grade prostate intraepithelial neoplasia","volume":"56","author":"Putzi","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.euf.2016.08.010_bib0510","first-page":"531","article-title":"CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia","volume":"7","author":"Brooks","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.euf.2016.08.010_bib0515","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0002-9440(10)63452-9","volume":"163","author":"Nakayama","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.euf.2016.08.010_bib0520","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/modpathol.2008.111","article-title":"Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis","volume":"21","author":"Gurel","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.euf.2016.08.010_bib0525","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1464-410x.2000.00388.x","article-title":"Bcl-2 proto-oncogene expression in low- and high-grade prostatic intraepithelial neoplasia","volume":"85","author":"Baltaci","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2016.08.010_bib0530","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/pros.20992","article-title":"Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia in human prostate","volume":"69","author":"Wang","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.euf.2016.08.010_bib0535","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2015.17703","article-title":"Nordic Twin Study of Cancer (NorTwinCan) Collaboration. Familial risk and heritability of cancer among twins in Nordic countries","volume":"315","author":"Mucci","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.euf.2016.08.010_bib0540","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng994","article-title":"Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk","volume":"32","author":"Xu","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.euf.2016.08.010_bib0545","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng823","article-title":"Germline mutations in the ribonuclease L gene in families showing linkage with HPC1","volume":"30","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.euf.2016.08.010_bib0550","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/pros.23147","article-title":"Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial","volume":"76","author":"Winchester","year":"2016","journal-title":"Prostate"},{"key":"10.1016\/j.euf.2016.08.010_bib0555","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/pros.22820","article-title":"Genetic variation across C-reactive protein and risk of prostate cancer","volume":"74","author":"Markt","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.euf.2016.08.010_bib0560","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1158\/1078-0432.CCR-12-2718","article-title":"A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer","volume":"19","author":"Schoenfeld","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euf.2016.08.010_bib0565","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/pcan.2012.30","article-title":"Genetic factors regulating inflammation and DNA methylation associated with prostate cancer","volume":"16","author":"Ianni","year":"2013","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euf.2016.08.010_bib0570","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1158\/1055-9965.EPI-12-0707","article-title":"Fine-mapping of IL16 gene and prostate cancer risk in African Americans","volume":"21","author":"Batai","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.euf.2016.08.010_bib0575","doi-asserted-by":"crossref","first-page":"e51680","DOI":"10.1371\/journal.pone.0051680","article-title":"Association of the innate immunity and inflammation pathway with advanced prostate cancer risk","volume":"7","author":"Kazma","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.euf.2016.08.010_bib0580","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/pros.22557","article-title":"Interleukin-6 promoter variants, prostate cancer risk, and survival","volume":"72","author":"Tindall","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.euf.2016.08.010_bib0585","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/pros.21423","article-title":"Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality","volume":"72","author":"Shui","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.euf.2016.08.010_bib0590","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1158\/1055-9965.EPI-10-0994","article-title":"Genetic polymorphisms in inflammation pathway genes and prostate cancer risk","volume":"20","author":"Kwon","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.euf.2016.08.010_bib0595","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/carcin\/bgp307","article-title":"PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: Results from the Breast and Prostate Cancer Cohort Consortium (BPC3)","volume":"31","author":"Dossus","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.euf.2016.08.010_bib0600","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/carcin\/bgq132","article-title":"Genetic variation in RNASEL associated with prostate cancer risk and progression","volume":"31","author":"Meyer","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.euf.2016.08.010_bib0605","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/carcin\/bgp124","article-title":"Cytokine genetic polymorphisms and prostate cancer aggressiveness","volume":"30","author":"Zabaleta","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.euf.2016.08.010_bib0610","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/carcin\/bgm277","article-title":"Interactions of cytokine gene polymorphisms in prostate cancer risk","volume":"29","author":"Zabaleta","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.euf.2016.08.010_bib0615","first-page":"3369","article-title":"Influence of cytokine gene polymorphisms on the development of prostate cancer","volume":"62","author":"McCarron","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.euf.2016.08.010_bib0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","article-title":"An investigation of polymorphism in the interleukin-10 gene promoter","volume":"24","author":"Turner","year":"1997","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.euf.2016.08.010_bib0625","first-page":"119","article-title":"Association of IL-10 polymorphisms with prostate cancer risk and grade of disease","volume":"19","author":"Faupel-Badger","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.euf.2016.08.010_bib0630","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/pros.20933","article-title":"Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II","volume":"69","author":"Wang","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.euf.2016.08.010_bib0635","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1158\/1055-9965.EPI-12-0458","article-title":"Variation in IL 10 and other genes involved in the immune response and in oxidation and in prostate cancer recurrence","volume":"21","author":"Dluznievski","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.euf.2016.08.010_bib0640","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ejca.2006.11.003","article-title":"Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: A population-based study","volume":"43","author":"Eder","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.euf.2016.08.010_bib0645","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1158\/0008-5472.CAN-05-3987","article-title":"Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer","volume":"66","author":"Michaud","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.euf.2016.08.010_bib0650","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nrurol.2013.266","article-title":"The genetic epidemiology of prostate cancer and its clinical implications","volume":"11","author":"Eeles","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euf.2016.08.010_bib0655","doi-asserted-by":"crossref","first-page":"e42273","DOI":"10.1371\/journal.pone.0042273","article-title":"Foxp4 is dispensable for T cell development, but required for robust recall responses","volume":"7","author":"Wiehagen","year":"2012","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.euf.2016.08.010_bib0660","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000312121","article-title":"Selective down-regulation of Th2 cytokines by C-terminal binding protein 2 in human T cells","volume":"152","author":"Kitamura","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.euf.2016.08.010_bib0665","doi-asserted-by":"crossref","first-page":"e48662","DOI":"10.1371\/journal.pone.0048662","article-title":"Nucleo-cytoplasmic trafficking of TRIM8, a novel oncogene, is involved in positive regulation of TNF induced NF-\u03baB pathway","volume":"7","author":"Tomar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.euf.2016.08.010_bib0670","doi-asserted-by":"crossref","first-page":"e49920","DOI":"10.1371\/journal.pone.0049920","article-title":"Centrosomal localization of the psoriasis candidate gene product, CCHCR1, supports a role in cytoskeletal organization","volume":"7","author":"Tervaniemi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.euf.2016.08.010_bib0675","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/ATVBAHA.113.302448","article-title":"Novel lipid droplet-associated serine hydrolase regulates macrophage cholesterol mobilization","volume":"34","author":"Goo","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.euf.2016.08.010_bib0680","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/mi.2013.76","article-title":"Pro-inflammatory effects of matrix metalloproteinase 7 in acute inflammation","volume":"7","author":"Vandenbroucke","year":"2014","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.euf.2016.08.010_bib0685","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.092134099","article-title":"Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans","volume":"99","author":"Zuo","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.euf.2016.08.010_bib0690","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.coph.2009.06.002","article-title":"Anti-inflammatory drugs, antioxidants, and prostate cancer","volume":"9","author":"Bardia","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.euf.2016.08.010_bib0695","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nrc886","article-title":"Are vitamin and mineral deficiencies a major cancer risk?","volume":"2","author":"Ames","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.euf.2016.08.010_bib0700","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1158\/1078-0432.CCR-10-2044","article-title":"Transcription-induced DNA double strand breaks: Both oncogenic force and potential therapeutic target?","volume":"17","author":"Haffner","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euf.2016.08.010_bib0705","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.613","article-title":"Androgen-induced TP2B-mediated double-strand breaks and prostate cancer gene rearrangements","volume":"42","author":"Haffner","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.euf.2016.08.010_bib0710","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ccr.2011.09.012","article-title":"Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG islands","volume":"205","author":"O\u2019Hagan","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.euf.2016.08.010_bib0715","first-page":"e1000155","article-title":"Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island","volume":"4","author":"O\u2019Hagan","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.euf.2016.08.010_bib0720","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1210\/en.2009-0573","article-title":"Epigenetic alteractions in human prostate cancers","volume":"150","author":"Nelson","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.euf.2016.08.010_bib0725","doi-asserted-by":"crossref","first-page":"8954","DOI":"10.1158\/0008-5472.CAN-07-6088","article-title":"DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contribution to metastatic tumor heterogenity","volume":"68","author":"Yegnasubramanian","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.euf.2016.08.010_bib0730","doi-asserted-by":"crossref","first-page":"169ra10","DOI":"10.1126\/scitranslmed.3005211","article-title":"DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases","volume":"5","author":"Aryee","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.euf.2016.08.010_bib0735","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1158\/2326-6066.CIR-15-0013","article-title":"A paracrine role for IL6 in prostate cancer patients: lack of production by primary or metastatic tumor cells","volume":"3","author":"Yu","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.euf.2016.08.010_bib0740","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1677\/ERC-09-0200","article-title":"Interleukin-6 trans-signaling differentially regulates proliferation, migration, adhesion, and maspin expression in human prostate cancer cells","volume":"17","author":"Santer","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.euf.2016.08.010_bib0745","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mce.2011.05.033","article-title":"Interleukin-6: A multifunctional targetable cytokine in human prostate cancer","volume":"360","author":"Culig","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.euf.2016.08.010_bib0750","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ijc.20286","article-title":"Interleukin-6 inhibits the growth of prostate cancer xenografts in mice by the process of neuroendocrine differentiation","volume":"111","author":"Wang","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.euf.2016.08.010_bib0755","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0002-9440(10)63859-X","article-title":"Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway","volume":"162","author":"Steiner","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.euf.2016.08.010_bib0760","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/pros.20553","article-title":"Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression","volume":"67","author":"Lee","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.euf.2016.08.010_bib0765","first-page":"4640","article-title":"Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor","volume":"58","author":"Hobisch","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.euf.2016.08.010_bib0770","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1677\/ERC-08-0174","article-title":"Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor","volume":"16","author":"Malinowska","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.euf.2016.08.010_bib0775","first-page":"5632","article-title":"P300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6","volume":"62","author":"Debes","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.euf.2016.08.010_bib0780","doi-asserted-by":"crossref","first-page":"38087","DOI":"10.1074\/jbc.M203313200","article-title":"Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells","volume":"277","author":"Ueda","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.euf.2016.08.010_bib0785","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/pros.1080","article-title":"Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice","volume":"48","author":"Smith","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.euf.2016.08.010_bib0790","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/0008-5472.CAN-05-3447","article-title":"Inhibition of interleukin-6 with CNTO 328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice","volume":"66","author":"Wallner","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.euf.2016.08.010_bib0795","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/pros.21362","article-title":"The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study","volume":"71","author":"Karkera","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.euf.2016.08.010_bib0800","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1158\/1078-0432.CCR-09-3122","article-title":"Clinical and correlative results of SWOG S0354: a phase II trial of CNTO 328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer","volume":"16","author":"Dorff","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euf.2016.08.010_bib0805","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1158\/0008-5472.CAN-13-0874","article-title":"JAK-STAT blockade inhibits tumor initiation and clongenic recovery of prostate cancer stem-like cells","volume":"73","author":"Kroon","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.euf.2016.08.010_bib0810","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ajpath.2012.08.011","article-title":"Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205","volume":"181","author":"Puhr","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.euf.2016.08.010_bib0815","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1158\/0008-5472.CAN-07-1162","article-title":"Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer","volume":"67","author":"Araki","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.euf.2016.08.010_bib0820","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.18632\/oncotarget.2052","article-title":"Tmor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells","volume":"5","author":"Maxwell","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.euf.2016.08.010_bib0825","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/carcin\/bgn109","article-title":"Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation","volume":"29","author":"Seaton","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.euf.2016.08.010_bib0830","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/biof.5520290103","article-title":"NF-kappa B as a potential molecular target for cancer therapy","volume":"29","author":"Lee","year":"2007","journal-title":"Biofactors"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240545691630133X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240545691630133X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:45:59Z","timestamp":1762497959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240545691630133X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S240545691630133X"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2016.08.010","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation, Microbiota, and Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2016.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}